戻る Agenda
FDA–Health Canada Regulatory Cooperation Council Town Hall
Session Chair(s)
Sema Hashemi, MSC
Senior International Policy Advisor
FDA, United States
The Regulatory Cooperation Council (RCC) was created in 2011 to develop smarter and more efficient and effective approaches to regulatory cooperation. FDA and Health Canada will highlight their work under RCC phase 2 and request stakeholder input on their current initiatives.
Learning Objective : Discuss FDA and Health Canada Regulatory Cooperation Council (RCC) priority areas over the next two years; Identify areas for stakeholders to contribute to the RCC process.
Speaker(s)
Panelist
Isabel Romero
Health Canada, Canada
Director, International Affairs